Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04729478
Other study ID # B3002021000006
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date March 30, 2021
Est. completion date December 31, 2022

Study information

Verified date July 2021
Source University Hospital, Antwerp
Contact Karlien Van den Bossche, MD
Phone 38212173
Email karlien.vandenbossche@uza.be
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Drug-induced sleep endoscopy (DISE) is the most used technique for identifying the obstruction site associated with obstructive sleep apnea (OSA). This is due to the fact that it allows many patients to be examined in a daytime setting. This procedure uses sedative drugs to mimic natural sleep. However, associations with the site of upper airway (UA) collapse during natural sleep remain unclear. The aim of this explorative study is to identify UA collapse in patients with OSA using endoscopic techniques as well as flow shape characteristics and sound analyses during natural and drug-induced sleep. Furthermore, we want to optimize the measurement set-up of natural sleep endoscopy (NSE).


Description:

Patients with moderate to severe OSA requiring DISE will be recruited for this prospective study at the outpatient clinic. Patients will undergo a NSE at the sleep lab at night, and a DISE at the operating theatre within three months. Both the NSE and DISE set-up will include gold-standard flow measurements, acoustic analysis and esophageal pressure measurements.


Recruitment information / eligibility

Status Recruiting
Enrollment 40
Est. completion date December 31, 2022
Est. primary completion date August 31, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Diagnosis of OSA with a baseline AHI = 15 per hour based on full polysomnography - Body mass index (BMI) = 35 kg/m² - Capability of giving informed consent and willingness to undergo NSE Exclusion Criteria: - Central sleep apnea (defined as CAHI = 30% of total AHI) - Inability to sleep in a supine position due to a medical condition - Inability of the patient to understand and/or comply to the study procedures - Neuromuscular disorders or craniofacial anomalies affecting the UA - Sedative medication use (opioids and muscle relaxants) - Active psychiatric disorders (psychotic illness, major depression, anxiety attacks, excessive alcohol or drug use) - Severe or decompensated cardiac or respiratory diseases - Medical history of known causes of tiredness by day or severe sleep disruption (insomnia, PLMS, narcolepsy) - Contra-indications for DISE: i.e. fitness for general anesthesia (ASA>3), allergy to sedative agent(s) and an expected extremely difficult airway - Pregnancy or willing to become pregnant

Study Design


Intervention

Device:
Drug-induced sleep endoscopy
An intravenous bolus injection of midazolam 1.5 mg will be used to induce sleep. Maintenance of sedated sleep will be obtained by a target-controlled infusion of propofol (2.0-3.0 µg/mL).
Natural sleep endoscopy
Endoscopy during natural sleep.

Locations

Country Name City State
Belgium Antwerp University Hospital Edegem Antwerp

Sponsors (1)

Lead Sponsor Collaborator
ethisch.comite@uza.be

Country where clinical trial is conducted

Belgium, 

Outcome

Type Measure Description Time frame Safety issue
Other Apnea-hypopnea index (AHI) The AHI is an index of sleep apnea severity that encompasses the frequency of apneas (cessations in breathing) and hypopneas (reductions in airflow). Immediately, during polysomnography
Other Oxygen desaturation index (ODI) The ODI represents the average number of desaturation episodes (=3%) per hour sleep. Immediately, during polysomnography
Other Oxygen saturation (SaO2) Minimal and mean SaO2 (%) Immediately, during polysomnography
Other Apnea index The apnea index is an index of sleep apnea severity that encompasses the frequency of apneas. Immediately, during polysomnography
Other Arousal index The arousal index is an indirect indicator of sleep apnea severity that encompasses the number of arousals related to total sleep time. Immediately, during polysomnography
Other Arousal threshold The occurrence of arousal from sleep with a rise in ventilatory drive. Immediately, during polysomnography
Other Daytime sleepiness measured with the Epworth Sleepiness Scale (ESS) The probability of falling asleep in various settings and situations in daily life will be assessed. This questionnaire consists of eight questions which can be scored on a four-point Likert-type scale. The lowest score (zero) suggests that the described incident is absent and the highest score (three) suggests the presence of this event. The summation of the eight items can range from 0 to 24. Immediately, before the procedure
Other Checklist Individual Strength questionnaire (CIS20R) for fatigue The checklist individual strength (CIS20R) is a 20-item questionnaire to assess the degree of fatigue. The patient selects the most appropriate score on each statement ranging from 1 (yes, this is true) to 7 (no, this is not true). The total score, calculated as the sum of the questions, may yield to a maximum of 140. The CIS20R measures four dimensions of fatigue: fatigue severity (8 items), concentration problems (5 items), reduced motivation (4 items) and activity (3 items). Immediately, before the procedure
Other Snoring intensity measured with a Visual Analogue Scale (VAS) The subjective degree of snoring during sleep will be evaluated by the partner of a subject by using a VAS scoring system ranging from 0 (no snoring) to 10 (extreme snoring causing the bed partner to sleep separately). Heavy snoring is determined as a snoring index =7. Immediately, before the procedure
Primary Endoscopic Classification System Comparison of the frequencies of the site, gradation and pattern of upper airway collapse between natural and drug-induced sleep endoscopy. Immediately, during the procedure
Secondary Flow shape analysis Several parameters extracted from the flow signal, including negative effort dependence (NED), peak inspiratory flow, etc. measured during both natural and drug-induced sleep endoscopy. Immediately, during the procedure
Secondary Acoustic analysis Acoustic analyses measured during both natural and drug-induced sleep endoscopy Immediately, during the procedure
See also
  Status Clinical Trial Phase
Completed NCT05582070 - Effect on Sleep of Surgical Treatment of Severe Nasal Obstruction N/A
Recruiting NCT03919955 - A Novel Pharmacological Therapy for Obstructive Sleep Apnea Phase 2
Completed NCT03927547 - Sleep Disordered Breathing and Cardiopulmonary Disease in Peruvian Highlanders N/A
Recruiting NCT04007380 - Psychosocial, Cognitive, and Behavioral Consequences of Sleep-disordered Breathing After SCI N/A
Completed NCT02188498 - Electrocardiography Data Analysis in Sleep Disorders
Completed NCT01503164 - Effects of Continuous Positive Airway Pressure (CPAP) on Glucose Metabolism N/A
Recruiting NCT00747890 - Surgical Treatment of Mild Obstructive Sleep Apnea N/A
Active, not recruiting NCT00738179 - Continuous Positive Airway Pressure Treatment of Obstructive Sleep Apnea to Prevent Cardiovascular Disease Phase 3
Completed NCT00841906 - Alice PDx User/Validation Extended Trial N/A
Completed NCT00202501 - Usefulness of Nasal Continuous Positive Airway Pressure (CPAP) Treatment in Patients With a First Ever Stroke and Sleep Apnea Syndrome N/A
Completed NCT00047463 - Effects of Treating Obstructive Sleep Apnea in Epilepsy Phase 2
Not yet recruiting NCT06029881 - Portable System for Non-intrusive Monitoring of Sleep
Recruiting NCT06093347 - Central Apnoea Monitor Study
Terminated NCT05445869 - Severe OSA Study (SOS) N/A
Withdrawn NCT04096261 - The Importance of Sleep Quality and the Blood-brain Barrier in Cognitive Disorders and Alzheimer's Disease
Recruiting NCT04575740 - Phenotyping Mechanistic Pathways for Adverse Health Outcomes in Sleep Apnea N/A
Completed NCT04676191 - Validation of a Contactless Vital Signs Measurement Sensor N/A
Recruiting NCT06015620 - Comorbidities Resolution After MGB Surgery and Change in Body Composition
Completed NCT06051097 - Metabolic Syndrome and Obstructive Sleep Apnea
Completed NCT05687097 - Untreated Sleep Apnea as an Aggravating Factor for Other Secondary Medical Conditions After Spinal Cord Injury